Clinical Trial Update: Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating aprepitant and ondansetron, alone or in combination, for postoperative nausea and vomiting in thyroid cancer patients; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Aprepitant (aprepitant)
• Ondansetron (ondansetron)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Thyroid Cancer | Phase 4 | Status: COMPLETED